| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.7M | -53.0% |
| SG&A Expense | $6.4M | -15.5% |
| Operating Income | -$12.9M | +75.4% |
| Pre-tax Income | -$14.7M | +71.7% |
| Income Tax | -$1.8M | +80.8% |
| Net Income | -$12.9M | +69.7% |
| EPS (Basic) | -$1.35 | -42.1% |
| EPS (Diluted) | -$1.35 | -42.1% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.0M | -17.5% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $722K | -10.0% |
| Current Assets | $24.0M | -18.0% |
| Total Assets | $73.3M | -7.4% |
| Current Liabilities | $1.7M | -50.6% |
| Total Liabilities | $11.6M | +3.5% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.3M | +22.5% |
| Investing Cash Flow | $104K | -99.2% |
| Financing Cash Flow | $7.4M | +2320.7% |
| Stockholders' Equity |
| $61.7M |
| -9.1% |